Loading...

1,830 posters, 67 videos, 75 audios, 29 topics, 22 sessions, 4,727 authors, 1,697 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2023

June 12 - 14, 2023 | London, UK

RCOG World Congress 2023 banner

EP.0074

Perinatal outcomes of monochorionic triplet pregnancies: Multicenter Cohort Study

Part of Topic

Fetal Medicine

Perinatal outcomes of monochorionic triplet pregnancies: Multicenter Cohort Study

Objective: to investigate the risk of early and late pregnancy complications, perinatal outcomes and the timing and methods of fetal intervention in monochorionic triamniotic (MCTA) triplet pregnancies.

Design: retrospective cohort study including MCTA triplet pregnancies managed in 21 Fetal Medicine Centers across the world.

Methods: MCTA triplet pregnancies were included. Data on maternal age, mode of conception, diagnosis of major fetal structural anomalies or aneuploidy, GA at diagnosis of anomalies, TTTS, TAPS, TRAP, or sFGR, antenatal interventions (including selective reduction (3 to 2 or 3 to 1)) were retrieved. Perinatal outcomes included livebirth, IUD, NND, PND, TOP, GA at birth, birthweight, NICU admission, and neonatal morbidity were also collected.

Results: in our cohort of MCTA triplet pregnancies (n=153 after excluding early miscarriages/TOP/lost to follow-up), 90% were managed expectantly. The incidence of fetal abnormalities and TRAP was 13.7% and 5.2%, respectively. TTTS, complicated 27.6% of the pregnancies, followed by sFGR (16.4%), while TAPS occurred in only 3.3%; no antenatal complication was recorded in 49.3% of pregnancies. Survival was largely associated with the development of these complications as shown in Table 1. The overall rates of PTB< 28 weeks and <32 weeks’ gestation were 14.5% and 49.2%, respectively.

Conclusions: MCTA triplet pregnancies constitute a challenge in counselling, surveillance and management: monochorionicity-related complications occur in almost half of these pregnancies with a negative impact on perinatal outcomes.

RCOG World Congress 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.